Przegląd Dermatologiczny

Abstract

3/2022 vol. 109
Case report

Narrow-band ultraviolet B as a treatment option in linear morphea

  1. Universitas Udayana/RSUP Sanglah, Indonesia
  2. Boston University Medical Center, Boston, USA
Dermatol Rev/Przegl Dermatol 2022, 108, 236–243
Online publish date: 2022/10/21
View full text
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease

Introduction

Morphea, also known as localized scleroderma, is a condition characterized by fibrosis of the skin and underlying tissue. Linear morphea is an infrequent condition especially in adults. Treatment of morphea is challenging because of its recalcitrant nature. Therapeutic options include the use of phototherapy and systemic immunosuppressants with variable success. Phototherapy used in morphea also varies, with ultraviolet A1 (UVA1) being the most frequently used therapy; however, the availability of UVA1 is scarce and may increase the risk of skin cancer. Narrow-band ultraviolet B (NB-UVB) is much more readily available and presents a much lower risk of skin cancer.

Case report

Here we report a 27-year-old adult male with linear morphea on his lower extremity treated using NB-UVB. The patient underwent twenty sessions of NB-UVB and showed remarkable response to therapy.

Conclusions

This case report further highlights a treatment option for linear morphea using NB-UVB.

Share
without publication fees
without publication fees